IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).

RTTNews | 816 ngày trước

IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.

RTTNews | 1082 ngày trước

Canadian Market Rebounds From Early Setback; Technology, Energy Stocks Rise

After opening with a big negative gap and dropping further down into the red Friday morning, the Canadian benchmark S&P/TSX Composite Index recovered gradually and was up modestly above the flat line a little past noon.

RTTNews | 1h 56phút trước

Bay Street Likely To Open On Weak Note

Lower Canadian and U.S. futures and weak metal prices point to a negative open for stocks on Bay Street Friday morning. Energy stocks may find some support thanks to higher crude oil prices and help limit the downside.

RTTNews | 6h 40phút trước

FTSE 100 Down Sharply As Bond Yields Climb Higher

UK stocks are falling on Friday with bond yields rising amid speculation Chancellor Rachel Reeves may backtrack on budget plans. The possibility of the Bank of England refraining from cutting interest rates due to fiscal concerns has raised concerns about fiscal and economic outlook.

RTTNews | 7h 37phút trước